Isogenica is currently seeking a Director of Antibody Discovery as we expand the scope of our activities to enable broader, deeper strategic relationships with biotech and pharmaceutical partners and to support internal VHH or Fab antibody discovery and pre-clinical development.  Leading teams to discover novel antibody drugs against therapeutically important but historically challenging targets will make this an exciting next career step for an ambitious and motivated leader.  Isogenica is working with global executive search firm, Virdis Group, to make this appointment.


Please contact Matthew Berry at Virdis Group (This email address is being protected from spambots. You need JavaScript enabled to view it.) if you wish to be considered for this role.